APA

Steigerwald I., Müller M., Davies A., Samper D., Sabatowski R., Baron R., Rozenberg S., Szczepanska-Szerej A., Gatti A. & Kress H. G. (20121105). Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. : Current medical research and opinion.

Chicago

Steigerwald Ilona, Müller Matthias, Davies Anthony, Samper Daniel, Sabatowski Rainer, Baron Ralf, Rozenberg Sylvie, Szczepanska-Szerej Anna, Gatti Antonio and Kress Hans G. 20121105. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. : Current medical research and opinion.

Harvard

Steigerwald I., Müller M., Davies A., Samper D., Sabatowski R., Baron R., Rozenberg S., Szczepanska-Szerej A., Gatti A. and Kress H. G. (20121105). Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. : Current medical research and opinion.

MLA

Steigerwald Ilona, Müller Matthias, Davies Anthony, Samper Daniel, Sabatowski Rainer, Baron Ralf, Rozenberg Sylvie, Szczepanska-Szerej Anna, Gatti Antonio and Kress Hans G. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. : Current medical research and opinion. 20121105.